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Cyclic AMP Suppresses Matrix Metalloproteinase-1
Expression through Inhibition of MAPK and GSK-3b
Chi-Hyun Park1,2,3, Youngji Moon1,2,3, Chung Min Shin1,2,3 and Jin Ho Chung1,2,3
Expression of matrix metalloproteinase-1 (MMP-1) is stimulated by diverse stimuli and is likely to be regulated
by many signaling pathways. cAMP is known to act as a second messenger for various extracellular stimuli and
to be involved in the regulation of cell proliferation, apoptosis, and inflammation. Here, we investigated the
effect of cAMP on tumor necrosis factor (TNF)-a-induced MMP-1 expression and the molecular events involved
in the processes in human skin fibroblasts. We showed that cAMP suppresses TNF-a-induced MMP-1 expression
via protein kinase A (PKA) pathway. cAMP inhibited TNF-a-stimulated ERK and JNK activation, which was shown
to have an important role in MMP-1 expression. However, MMP-1 expression could also be inhibited by cAMP
even when ERK and JNK activities were unaffected, indicating that there might be other target(s) that mediate
cAMP-mediated suppression of MMP-1 expression. Further studies revealed that glycogen synthase kinase
(GSK)-3b can be inactivated by cAMP/PKA pathway and has important roles in MMP-1 expression, and showed
that inactivation of GSK-3b is critical for suppression of MMP-1 expression by cAMP elevation after TNF-a
treatment. Taken together, our results suggest that cAMP/PKA pathway can suppress MMP-1 expression through
inhibition of multiple signaling pathways, including MAPK and GSK-3b.
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INTRODUCTION
Matrix metalloproteinases (MMPs) constitute a family of
structurally related zinc-dependent endopeptidases that are
capable of degrading a wide variety of extracellular matrix
components (Kahari and Saarialho-Kere, 1997; Woessner,
1998; Nagase et al., 2006). MMPs are known to have
important roles in tissue remodeling during physiological
processes, including developmental morphogenesis, angio-
genesis, and tissue repair, and in tissue destruction during
pathological processes, such as arthritis, skin aging, tumor
invasion, and metastasis. To date, 23 human MMP gene
family members have been identified (Nagase et al., 2006;
Lopez-Otin et al., 2009). These can be classified into
subgroups of collagenases, gelatinases, stromelysins, mem-
brane-type MMPs, and other MMPs, according to their
structure and substrate specificities (Nagase and Woessner,
1999; Sternlicht and Werb, 2001; Nagase et al., 2006).
Human fibroblasts have the capacity to produce several
MMPs, including interstitial collagenase (collagenase-1,
MMP-1), stromelysin-1 (MMP-3), and 72-kDa gelatinase
(MMP-2). The expression of MMPs is usually low in non-
stimulated cells, but some are induced by various extracellular
stimuli including growth factors, proinflammatory cytokines,
tumor promoters, and ultraviolet (UV) and infrared (IR) radiation
(Johansson et al., 2000; Sternlicht and Werb, 2001; Rittie and
Fisher, 2002; Cho et al., 2008; Schroeder et al., 2008).
The second messenger cAMP has been reported to
regulate a variety of cellular activities through cell-type-
specific responses (Houslay and Milligan, 1997). cAMP is
generated from ATP by adenylate cyclases and converted to
50-AMP by phosphodiesterases (Sunahara and Taussig, 2002;
Houslay and Adams, 2003). Intracellular cAMP levels can be
increased by various extracellular stimuli including hor-
mones, growth factors, and neurotransmitters through G-
protein (Gs)-coupled membrane receptors (Sunahara and
Taussig, 2002). In addition, the cellular cAMP level can be
stimulated by a variety of pharmacological agents, such as
forskolin, which is a direct activator of adenylate cyclases
(Seamon et al., 1981), isobutylmethylxanthine (IBMX), which
is an inhibitor of phosphodiesterases (Beavo et al., 1970), and
dibutyryl cAMP, a cell-permeable cAMP (Schmidt-Ott et al.,
2001). Elevated cAMP activates its downstream effectors,
including protein kinase A (PKA) and exchange proteins
directly activated by cAMP (Epac), also known as cAMP-
regulated guanine nucleotide exchange factors (cAMP–GEFs),
which mediate various biological functions of cAMP in a cell-
type-specific manner (Doskeland et al., 1993; de Rooij et al.,
1998; Feliciello et al., 2005).
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Although numerous studies have reported that cAMP
signaling pathways have important roles in regulating a
variety of biological processes such as cell proliferation and
growth, apoptosis, carcinogenesis, inflammation, and im-
mune response (Rosenberg et al., 2002; Schmitt and Stork,
2002; Stork and Schmitt, 2002; Peters-Golden, 2009), the
role of cAMP signaling on expression of MMPs remains
poorly understood. In this study, we investigated the effect of
cAMP on the expression of MMP-1 induced by diverse
stimuli, including tumor necrosis factor (TNF)-a, and the
signal transduction pathways involved in this process in
human skin cells. We found that elevation of cAMP inhibited
MMP-1 expression induced by TNF-a, interleukin (IL)-1b, and
epidermal growth factor (EGF), and that the suppression of
MMP-1 by cAMP was mediated via PKA but not Epac. Further
studies indicated that elevation of cAMP before or after
TNF-a treatment might attenuate MMP-1 expression through
the suppression of TNF-a-induced activation of extracellular
signal-regulated kinase (ERK) and c-Jun N-terminal kinase
(JNK) and/or the inactivation of glycogen synthase kinase
(GSK)-3b, which, in this study, was shown to have an
important role in MMP-1 expression. Therefore, our results
show that cAMP/PKA pathway can suppress MMP-1 expression
through the regulation of multiple signaling pathways, including
mitogen-activated protein kinase (MAPK) and GSK-3b.
RESULTS
Elevation of cAMP inhibits TNF-a-induced MMP-1 expression in
human skin fibroblasts
Previous studies have shown that cAMP signaling may have
an important role in inhibiting MMP-1 expression in several
cell lines (Salvatori et al., 1992). However, the molecular
mechanisms involved in the process remain poorly under-
stood. To investigate the effect of cAMP elevation on the
expression of MMP-1 in more detail, cultured human skin
fibroblasts were pretreated with a cAMP-elevating agent,
forskolin, for 45minutes at the indicated concentrations,
followed by treatment with or without TNF-a for 24 hours.
The mRNA levels of MMP-1 were measured by quantitative
real-time PCR and the protein levels of MMP-1 released into
culture media were analyzed by western blot analysis.
Forskolin suppressed TNF-a-induced expression of MMP-1
at both the mRNA and the protein levels in a dose-dependent
manner (Figure 1a and b). Furthermore, pretreatment of
cells with two other cAMP-elevating agents, IBMX and
dibutyryl cAMP for 60minutes also attenuated TNF-a-
induced MMP-1 protein expression in a dose-dependent
manner (See online Supplementary Figure S1a and b). Taken
together, these results indicate that elevation of cAMP
suppresses TNF-a-induced MMP-1 expression in primary
human skin fibroblasts.
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Figure 1. Elevation of cAMP inhibits TNF-a-induced MMP-1 expression via PKA but not Epac in human skin fibroblasts. (a, b) Serum-starved primary human
skin fibroblasts were pretreated with forskolin (FSK) at the indicated concentrations for 45minutes and then treated with vehicle only (CON) or TNF-a
(5 ngml–1; TNF-a) for 24 hours. (c) Serum-starved primary human skin fibroblasts were pretreated first with DMSO only (C), the Akt inhibitor, Akt Inhibitor VIII
(10mM; V), or the PKA inhibitor, H-89 (10mM; H), for 1 hour and then with DMSO (C) or forskolin (10mM; F) for 45minutes. Cells were then treated with
vehicle only (CON) or TNF-a (5 ng/ml; TNF-a) for 24 hours. (d) Serum-starved primary human skin fibroblasts were pretreated with DMSO only (C), forskolin
(10mM; F), the specific PKA agonist, 6-Bnz-cAMP (0.2mM; 1–1, 1.0mM; 1–2), or the specific Epac agonist, 8-pCPT-2-O-Me-cAMP (0.2mM; 2–1, 1.0mM; 2–2),
for 45minutes. Cells were then treated with vehicle only (CON) or TNF-a (5 ngml–1; TNF-a) for 24 hours. The MMP-1 mRNA levels in the cells (a) were analyzed
by real-time PCR. Each level of MMP-1 mRNA was normalized versus that of the corresponding GAPDH mRNA. The amounts of MMP-1 protein released
into culture media (b–d) were analyzed by western blotting. Data shown are representative of three independent experiments. Values represent the mean±SD of
data from three independent experiments. (a, b, d) *Po0.05, **Po0.01 versus TNF-a only, (c) *Po0.05, **Po0.01.
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PKA but not Epac is critical for cAMP- mediated inhibition of
MMP-1 expression
It has been reported that many biological activities of cAMP
are mediated through the PKA pathway (Houslay and
Milligan, 1997; Mayr et al., 2001; Schmitt and Stork, 2002),
even though recent studies have shown that some biological
functions of cAMP can also be mediated by Epac (Borland
et al., 2009; Woolson et al., 2009). To investigate whether
the PKA pathway is specifically involved in cAMP-mediated
MMP-1 suppression, cultured human skin fibroblasts were
pretreated with a specific Akt inhibitor, Akt Inhibitor VIII, or a
PKA inhibitor, H-89, for 1hour, followed by treatment with
forskolin for 45minutes, and then stimulation with TNF-a for
24hour. TNF-a-induced MMP-1 expression from the cells
pretreated with Akt Inhibitor VIII or H-89 was slightly, but not
significantly, increased, compared with that from cells pretreated
with vehicle only. However, H-89, but not Akt Inhibitor VIII,
antagonized cAMP-mediated suppression of MMP-1 expression,
indicating that PKA activity specifically mediates the effect
of cAMP on MMP-1 expression (Figure 1c). Furthermore, to
confirm these results and to test whether another cAMP effector,
Epac, is also involved in the MMP-1 suppression, human skin
fibroblasts were pretreated with 6-Bnz-cAMP, a specific PKA
agonist, or 8-pCPT-20-O-Me-cAMP, a specific Epac agonist, for
30minutes, and then treated with TNF-a for 24hour. Only
6-Bnz-cAMP, but not 8-pCPT-20-O-Me-cAMP, suppressed
TNF-a-induced MMP-1 expression (Figure 1d). Taken together,
these results indicate that the inhibition of MMP-1 expression by
cAMP is mediated by PKA but not Epac.
Elevation of cAMP inhibits ERK and JNK activities, which have
an important role in TNF-a-induced MMP-1 expression
It has been reported that the cAMP-signaling pathway can
regulate MAPK either positively or negatively, depending on
the stimulus and/or the cell type (Houslay and Kolch, 2000;
Stork and Schmitt, 2002) and that ERK and JNK have a crucial
role in the expression of MMP-1 induced by various
extracellular stimuli including UV, heat shock, and phorbol
12-myristate 13-acetate (PMA) (Reunanen et al., 1998, 2002;
Westermarck et al., 1998; Park et al., 2004; Kim et al., 2005).
Therefore, we wondered whether TNF-a-induced ERK and
JNK activities would also be affected by cAMP and, if so,
whether they would have a role in MMP-1 expression in
human skin fibroblasts. To test this possibility, we treated
cultured fibroblasts with TNF-a, harvested the cells at various
time points, and examined the activation of ERK and JNK by
western blot analysis with antibodies against the phosphory-
lated forms of these MAPK. Our results showed that TNF-a
induced the rapid and strong activation of ERK and JNK, as
the phosphorylated forms of these two MAPK were detected
and peaked at 15minutes and then returned to their basal
levels at 30minutes (Figure 2a). Therefore, we pretreated
cultured fibroblasts for 45minutes with or without forskolin
and then treated the cells with TNF-a for 15minutes. TNF-a-
stimulated ERK and JNK activation at 15minutes were
significantly attenuated by forskolin. However, previous
treatment of cells with H-89, a PKA inhibitor, further
increased TNF-a-stimulated ERK and JNK activation and
significantly abrogated the suppression of TNF-a-stimulated
ERK and JNK activation by forskolin (Figure 2b), indicating
that basal and forskolin-induced PKA activities have a role in
suppressing the activation of ERK and JNK in human skin
fibroblasts. We also investigated the role of ERK and JNK in
TNF-a-induced MMP-1 expression. The inhibition of ERK and
JNK by pretreatment with U0126, a MEK inhibitor, and
SP600125, a JNK inhibitor, respectively, reduced the MMP-1
expression at both the mRNA and the protein levels (Figure
2c and d), confirming that ERK and JNK have an important
role in TNF-a-induced MMP-1 expression in human skin
fibroblasts. Taken together, our results suggest that cAMP/
PKA pathway may suppress TNF-a-induced MMP-1 expres-
sion through the inhibition of ERK and JNK activities.
TNF-a-induced MMP-1 expression can be suppressed by cAMP,
even when ERK and JNK activities are unaffected by it
Next, we were interested in whether the ERK and JNK
pathways were the only targets through which cAMP
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Figure 2. cAMP/PKA pathway inhibits ERK and JNK activities, which have
important roles in TNF-a-induced MMP-1 expression. (a) Serum-starved
primary human skin fibroblasts were treated with TNF-a (5 ngml–1) for the
indicated times. Activation of ERK and JNK were analyzed in total cell lysates
by western blotting using antibodies against phosphorylated forms of ERK and
JNK, respectively. Total protein levels were analyzed with antibodies against
ERK or JNK1. (b) Serum-starved primary human skin fibroblasts were pre-
treated first with DMSO only (C), or the PKA inhibitor, H-89 (10 mM; H), for
1 hour and then with DMSO (C) or forskolin (10 mM; F) for 45minutes. Cells
were then treated with vehicle only (CON) or TNF-a (5 ngml–1; TNF-a) for
24 hours. Activation of ERK and JNK were analyzed in total cell lysates by
western blotting using antibodies against phosphorylated forms of ERK and
JNK, respectively. Total protein levels were analyzed with antibodies against
Akt. (c, d) Serum-starved fibroblasts were pretreated with DMSO only (C),
U0126, a MEK inhibitor (20mM; U), or SP600125, a JNK inhibitor (20 mM; SP)
for 1 hour and then treated with vehicle only (CON) or TNF-a (5 ngml–1;
TNF-a) for 24 hours. The MMP-1 mRNA levels in the cells (c) were analyzed
by real-time PCR. Each level of MMP-1 mRNA was normalized versus that of
the corresponding GAPDH mRNA. The amounts of MMP-1 protein released
into culture media (d) were analyzed by western blotting. Data shown are
representative of three independent experiments. Values represent the
mean±SD of data from three independent experiments. ***Po0.001 versus
TNF-a only.
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regulated MMP-1 expression. Therefore, we pretreated
cultured fibroblasts with forskolin at various time points,
treated with TNF-a, and measured the activities of ERK and
JNK in total cell lysates at 15minutes and the MMP-1 protein
levels in culture media at 24 hours post-treatment. TNF-a-
induced ERK and JNK activation were attenuated when cells
were pretreated with forskolin for 30 or 60minutes but not at
0, 120, or 240minutes before TNF-a treatment (Figure 3),
indicating that the inhibition of TNF-a-stimulated ERK and
JNK activation by cAMP elevation requires pretreatment of
the cells with forskolin within a specific time frame before
TNF-a treatment. In contrast, TNF-a-induced MMP-1 expres-
sion was inhibited by cAMP at all time points (Figure 3), even
when TNF-a-induced ERK and JNK activation were unaf-
fected by cAMP. These results indicate that there might be
other target(s) that mediate the suppression of MMP-1
expression by cAMP.
cAMP/PKA pathway inhibits GSK-3b activity, which has a
critical role in MMP-1 expression
GSK-3b has been shown to regulate many transcription
factors, including p53, b-catenin, and NF-kB, and the
expression of various genes (Beurel and Jope, 2006; Rocques
et al., 2007). In addition, studies have reported that PKA and
PKC, in addition to PKB/Akt, can phosphorylate GSK-3b at
serine 9 in some cell lines, leading to the inactivation of GSK-
3b activity (Goode et al., 1992; Fang et al., 2000). Therefore,
we were interested in whether cAMP could also phosphor-
ylate GSK-3b at serine 9 in human skin fibroblasts. To test
this, we treated cultured cells with forskolin, harvested the
cells at various time points (from 0 to 240minutes), and
checked the phosphorylation by western blot analysis.
Phosphorylation of GSK-3b at serine 9 was increased
by forskolin at 15minutes and then reduced to the basal
level at 30minutes post-treatment (Figure 4a). However, the
phosphorylation of GSK-3b at serine 9 by cAMP was
significantly reduced by pretreatment with H-89, indicating
that cAMP phosphorylates GSK-3b at serine 9 via PKA in
human skin fibroblasts (Figure 4b). We then investigated
the role of GSK-3b in MMP-1 expression. First, cultured
fibroblasts were pretreated with NaCl (as a control) or LiCl (as
a well-known GSK-3 inhibitor) at different concentrations
and treated with TNF-a; the levels of MMP-1 mRNA in cells
and protein in culture media were measured at 24 hours post-
treatment. LiCl but not NaCl reduced TNF-a-induced MMP-1
expression at both the mRNA and the protein levels in a dose-
dependent manner (Figure 4c and d). In addition, pretreat-
ment of the cells with two structurally different GSK-3 inhi-
bitors, AR-A014418 and SB415286, also inhibited TNF-a-
induced MMP-1 protein expression in a dose-dependent
manner (See online Supplementary Figure S2a and b),
indicating that GSK-3b has a crucial role in MMP-1
expression in human skin fibroblasts. Taken together, our
results indicate that activation of the cAMP/PKA pathway can
immediately inactivate GSK-3b, which, in this study is shown
to have a critical role in MMP-1 expression in human skin
fibroblasts.
TNF-a-induced MMP-1 expression can be suppressed by
activation of cAMP pathway or inhibition of GSK-3 activity
several hours after TNF-a treatment
We further investigated the effects of cAMP pathway and
GSK-3 activity on MMP-1 expression but focused on their
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Figure 3. TNF-a-induced MMP-1 expression can be inhibited by cAMP-
signaling pathway, even when ERK and JNK activities are unaffected by
cAMP elevation. Serum-starved primary human skin fibroblasts were
pretreated with DMSO only (C) or forskolin (10 mM; F) at the indicated times
and then treated with vehicle only (CON) or TNF-a (5 ngml–1; TNF-a) for
15minutes or 24 hours. The protein levels of each kinase indicated above
were analyzed in total cell lysates at 15minutes, and the MMP-1 and MMP-2
protein levels in culture media at 24 hours were analyzed by western blotting.
Data shown are representative of three independent experiments.
0 15Time (min)
p-GSK-3β(S9) p-GSK-3β(S9)
t-GSK-3β t-GSK-3β
MMP-1
CON
40
40
20
R
el
at
ive
m
R
N
A 
le
ve
l
*
**
20
0
0
40
40
20
20
0
0
40
40
20
20
0
0
40
40
20
20
0
0
1.2
1
0.8
0.6
0.4
0.2
0 R
el
at
ive
pr
ot
ei
n 
le
ve
l
*
**
1.2
1
0.8
0.6
0.4
0.2
0
TNF-α
CON FSK
CON
C H C H
TNF-α
NaCl (mM)
LiCl  (mM)
NaCl (mM)
LiCl  (mM)
30 60 120 240
Forskolin
Figure 4. cAMP/PKA pathway induces the phosphorylation of GSK-3b at
serine 9, and GSK-3 has an important role in TNF-a-induced MMP-1
expression. (a) Serum-starved primary human skin fibroblasts were treated
with forskolin (10 mM) at the indicated times. (b) Serum-starved fibroblasts
were pretreated with DMSO only (C) or H-89 (10 mM; H) for 1 hour and then
treated with DMSO only (CON) or forskolin (10mM; FSK) for 15minutes. The
protein levels of each kinase indicated above in total cell lysates were
analyzed by western blotting. (c, d) Serum-starved primary human skin
fibroblasts were pretreated with NaCl or LiCl at the indicated concentrations
and then treated with vehicle only (CON) or TNF-a (5 ngml–1; TNF-a) for
24 hours. The MMP-1 mRNA levels in the cells (c) were analyzed by real-time
PCR. Each level of MMP-1 mRNA was normalized versus that of the
corresponding GAPDH mRNA. The amounts of MMP-1 protein released into
culture media (d) were analyzed by western blotting. Data shown are
representative of three independent experiments. Values represent the
mean±SD of data from three independent experiments. *Po0.05, **Po0.01
versus TNF-a only.
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effects on MMP-1 expression after the activation of ERK and
JNK by TNF-a had already occurred. To do this, we first
pretreated the cells with TNF-a and then treated with or
without forskolin (Figure 5a) or SB415286 (Figure 5b)
immediately (at 0 hour) and at 2, 4, 6, and 8 hours,
respectively. The MMP-1 protein levels in culture media
were measured at 24 hours post-TNF-a treatment. Our results
showed that TNF-a-induced MMP-1 expression was inhibited
by either activation of cAMP pathway or inhibition of GSK-3
activity, even several hours after TNF-a treatment (Figure 5a
and b). These results suggest that GSK-3 activity and/or other
factors that may be regulated by cAMP/PKA pathway are
required at least up to 8 hours post-treatment for efficient
induction of MMP-1 by TNF-a in human skin fibroblasts.
cAMP-mediated, but ERK- and JNK-independent, suppression of
MMP-1 expression is mediated through inhibition of GSK-3b
To examine whether cAMP-mediated but ERK- and JNK-
independent suppression of MMP-1 expression was mainly
mediated by inhibition of GSK-3b, we transiently transfected
human skin fibroblasts with the control vector only or the
vector containing either the wild-type or a constitutively
active form of GSK-3b for 24 hours. The transfected cells
were serum-starved for 24 hours, treated with forskolin at
4 hours after TNF-a addition, and further incubated for
24 hours. The GSK-3b protein levels in total cell lysates and
the MMP-1 protein levels in culture media were measured
by western blot analysis. The wild-type and constitutively
active form of GSK-3b were equally or similarly expressed
(Figure 5c). However, the suppression of TNF-a-induced
MMP-1 expression by cAMP was significantly abrogated
by overexpression of a constitutive active form, but not
the wild-type, of GSK-3b. These results indicate that
suppression of TNF-a-induced MMP-1 expression by cAMP
elevation after TNF-a treatment is mediated by inhibition of
GSK-3b, independently of the regulation of ERK and JNK
pathways.
Activation of cAMP pathway also suppresses the expression of
MMP-1 induced by IL-1b and EGF in human skin fibroblasts
Next, we investigated whether the expression of MMP-1
induced by other extracellular stimuli could be affected by
cAMP pathway in human skin fibroblasts. We pretreated
cultured fibroblasts with forskolin or IBMX for 1 hour before
treatment with IL-1b or EGF, or treated the cells with forskolin
at 4 hours after addition of IL-1b or EGF. The amounts of
MMP-1 protein in culture media were measured at 24 hour
after treatment with IL-1b or EGF by western blot analysis. As
shown in Supplementary Figure S3, the expressions of MMP-
1 induced by IL-1b or EGF were significantly suppressed by
pretreatment or post-treatment with forskolin or IBMX in
human skin fibroblasts, indicating that the cAMP pathway
can regulate the expression of MMP-1 induced by various
stimuli, including TNF-a, in human skin fibroblasts.
DISCUSSION
MMP-1 is known to have an important role in matrix
remodeling in many physiological and pathological pro-
cesses and its expression is regulated by diverse signaling
pathways. Even though it has been reported that elevation of
cAMP can repress MMP-1 expression (Salvatori et al., 1992),
the molecular mechanisms involved in this process have not
been elucidated. In this study, we investigated the effect of
cAMP elevation on MMP-1 expression in more detail and the
underlying mechanisms involved in this process in human
skin cells. Our studies showed that the expression of MMP-1
induced by TNF-a is suppressed by several cAMP-elevating
agents such as forskolin, IBMX, and dibutyryl cAMP and that
the suppression of MMP-1 expression by cAMP is mediated
by PKA but not Epac. Many studies have shown that the
transcription factor AP-1 has an important role in the
expression of MMP-1 induced by diverse stimuli including
UV and PMA (Gutman and Wasylyk, 1990; Rittie and Fisher,
2002). The AP-1 transcription factor is composed of
homodimeric or heterodimeric complexes containing c-Fos
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Figure 5. Suppression of MMP-1 expression by elevation of cAMP after TNF-a treatment is mediated through inhibition of GSK-3b. (a, b) Serum-starved
primary human skin fibroblasts were treated with vehicle only (CON) or TNF-a (5 ngml–1; TNF-a) followed by treatment with DMSO only (C) or forskolin (10 mM;
F) or SB415286 (50 mM; SB) at the indicated times. The MMP-1 and MMP-2 protein levels in culture media at 24 hours after TNF-a treatment were analyzed
by western blotting. (c) Primary skin fibroblasts were transfected with a control plasmid (CON) or the plasmids for expressing the wild-type (WT) or a
constitutively active form (S9A) of GSK-3b for 24 hours. Then the transfected cells were serum-starved for 24 hours and treated with vehicle only (CON) or TNF-a
(5 ngml–1; TNF-a), followed by treatment with DMSO only (C) or forskolin (10mM; F) at 4 hours post-treatment. The protein levels of HA-GSK-3b WT,
HA-GSK-3b S9A, or b-actin in total cell lysates and the MMP-1 protein levels in culture media at 24 hours after TNF-a treatment were analyzed by western
blotting. Data shown are representative of three independent experiments. Values represent the mean±SD of data from three independent experiments.
**Po0.01.
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and c-Jun family members whose activities are regulated by
ERK and JNK (Karin, 1995). The ERK pathway increases the
expression of these AP-1 components. JNK phosphorylates c-
Jun at serine 63 and serine 73, which stabilizes c-Jun protein
and increases its transcriptional activity (Karin, 1995; Karin
and Hunter, 1995; Davis, 2000). It has been reported that the
cAMP/PKA pathway regulates ERK and JNK pathways in
some types of cells (Schmitt and Stork, 2002; Zhang et al.,
2008). In agreement with these reports, we found that cAMP
elevation also suppresses TNF-a-induced ERK and JNK
activation in human skin fibroblasts. In addition, our results
showed that ERK and JNK also have a critical role in TNF-a-
induced MMP-1 expression. Therefore, these results indicate
that the inhibition of MMP-1 expression by the cAMP/PKA
pathway may be mediated, at least in part, by suppression of
ERK and JNK in human skin fibroblasts.
Although ERK and JNK have a critical role in MMP-1
expression, there are obviously other signaling pathways that
regulate MMP-1 expression (Jinnin et al., 2005; Faour et al.,
2006). Therefore, we wondered whether ERK and JNK were
the only targets that mediate the suppression of MMP-1
expression by cAMP/PKA. Our results showed that cAMP
elevation could inhibit TNF-a-induced MMP-1 expression,
even when TNF-a-induced ERK and JNK activation were not
inhibited by cAMP, such as when forskolin was treated
immediately before or after TNF-a addition, or even at several
hours after TNF-a treatment. This led us to assume that there
might be other target(s) that is responsible for suppression of
MMP-1 expression by cAMP. It has been shown that the
cAMP/PKA pathway can regulate many signaling molecules
or transcription factors either directly by phosphorylation or
indirectly through synthesis of new proteins (Stork and
Schmitt, 2002; Feliciello et al., 2005; Zhang et al., 2005).
Among them, we focused on GSK-3b, which had been shown
to be phosphorylated at serine 9 and therefore inactivated by
PKA (Li et al., 2000; Torii et al., 2008). Indeed, we found that
GSK-3b could be phosphorylated at serine 9 via the PKA
pathway within 15minutes after forskolin treatment. In
addition, we also found that GSK-3b has a critical role in
TNF-a-induced MMP-1 expression in human skin fibroblasts.
Then we showed that cAMP-mediated suppression of TNF-a-
induced MMP-1 expression is significantly attenuated by
overexpression of a constitutively active form, but not the
wild-type, of GSK-3b, when forskolin is added at 4 hours after
TNF-a treatment. These results indicate that the suppression
of MMP-1 expression by cAMP elevation, especially after
TNF-a treatment, is mainly mediated by inhibition of GSK-3b
activity via the PKA pathway in human skin fibroblasts.
Intracellular cAMP levels can be increased by diverse
stimuli including hormones, growth factors, and neurotrans-
mitters through G-protein (Gs)-coupled membrane receptors
(Sunahara and Taussig, 2002). In addition, prostaglandin E2
(PGE2) has been reported to increase intracellular cAMP
when it binds to two subtypes of its receptors, EP2 and EP4
(Sugimoto and Narumiya, 2007). The PGE2 levels can be
increased by various extracellular stimuli such as TNF-a,
IL-1b, and UV via induction of cyclooxygenase-2 (COX-2),
which has an important role in the generation of various PGs
including PGE2 from arachidonic acid (Brenneisen et al.,
1999; Smith and Langenbach, 2001). Therefore, considering
that cAMP elevation can inhibit MMP-1 expression several
hours after treatment with extracellular stimuli, it is possible
that the increase of intracellular cAMP levels by COX-2 and
PGE2, whose induction precedes MMP-1 expression (Chen
et al., 2001; Lee et al., 2009), may negatively regulate MMP-1
expression. In fact, it has been recently reported that TNF-a
increases PGE2 via COX-2 and that PEG2 inhibits TNF-a-
induced MMP-1 expression in a cAMP-dependent manner, in
synovial fibroblasts (Kunisch et al., 2009). We have also
found that intracellular cAMP levels are increased by TNF-a
in human skin fibroblasts (See online Supplementary
Figure S4). Further studies are ongoing for understanding
the underlying mechanisms by which TNF-a regulates
intracellular cAMP levels and the role of the increased cAMP
in the expression of various genes regulated by TNF-a,
including MMP-1, in human skin fibroblasts.
In this study, we have revealed that GSK-3b activity is
required for the MMP-1 expression induced by TNF-a. To our
knowledge this is previously unreported. Furthermore, we
have shown that GSK-3b activity is critical for MMP-1
induction, even 8 hours after TNF-a treatment. In fact, the
steady-state levels of MMP-1 mRNA seem to increase
gradually and continuously over 24 hours after TNF-a
treatment (data not shown). Therefore, our results suggest
that GSK-3b activity is necessary for continuous increase of
MMP-1 mRNA levels over several hours upon stimulation
with extracellular stimuli such as TNF-a in human skin
fibroblasts. Many studies have shown that GSK-3b regulates
various transcription factors such as c-Jun and STAT (de Groot
et al., 1993; Beurel and Jope, 2008). It has been also reported
that NF-kB-dependent gene expressions are differentially
regulated by GSK-3b (Steinbrecher et al., 2005). However, at
this moment, we do not know how GSK-3b regulates MMP-1
expression. Further work is required to elucidate the
molecular mechanisms of GSK-3b-mediated regulation of
MMP-1 expression.
In summary, our present studies elucidate the molecular
mechanisms by which cAMP regulates the MMP-1 expression
induced by extracellular stimuli including TNF-a and show
that GSK-3b has an important role in MMP-1 expression in
human skin fibroblasts. Increased MMP-1 expression has been
shown to be associated with matrix degradation in skin aging
and skin carcinogenesis (Airola and Fusenig, 2001; Brenneisen
et al., 2002; Rittie and Fisher, 2002). Therefore, our results may
help in development of clinical strategies to control skin
diseases related with deregulated matrix metabolism.
MATERIALS AND METHODS
Materials
A control plasmid (pDNA3–EGFP) was obtained from Invitrogen
(Carlsbad, CA). Expression plasmids for HA-GSK-3b WT and S9A
were kindly provided by Dr JW Woodgett.
Cell culture and treatments
Primary human foreskin fibroblasts were established and cultured as
described previously (Park et al., 2004). For treatment, primary
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human skin fibroblasts were serum-starved for 24–48 hours in DMEM
containing 0.25% FBS. The medical ethical committee of Seoul
National University approved all described studies, and the
participants gave their written informed consent. The study was
conducted according to Declaration of Helsinki Principles.
Transfection
Primary human skin fibroblasts were transiently transfected using
FuGENE HD (Roche Applied Science, Indianapolis, IN) according to
the manufacturer’s protocol.
RNA analysis
Total RNA and the first-strand cDNA were prepared as described
previously (Park et al., 2004; Li et al., 2007). Quantitative real-time
PCR was performed using an Applied Biosystems 7500 Real-time
PCR system (Applied Biosystems, Foster City, CA) and SYBR Premix
Ex Taq (Perfect Real Time) (Takara Bio, Shiga, Japan) using the
following primers for human genes: GAPDH (forward, 50-CAATGA
CCCCTTCATTGACC-30; reverse, 50-AAATGAGCCCCAGCCTTCT-30),
MMP-1 (forward, 50-AAGCGTGTGACAGTAAGCTA-30; reverse,
50-AACCGGACTTCATCTCTG-30).
Western blot analysis
The amounts of MMP-1 and MMP-2 proteins secreted into culture
media were analyzed as described previously (Park et al., 2004; Li
et al., 2007). In contrast to that of MMP-1, the expression of MMP-2
was not significantly (if any, only very slightly) affected by most of
the agents used in this study, including TNF-a, the cAMP-elevating
agent, forskolin, and the GSK-3 inhibitor, SB415286, as shown in
Figures 3 and 5. Therefore, we used MMP-2 as a loading control for
MMP-1 released into culture media (data not shown). The proteins in
cells were analyzed using total cell lysates as described previously
(Park et al., 2004). Antibodies against b-actin were purchased from
Santa Cruz Biotechnology (Santa Cruz, CA) and all other antibodies
were from Cell Signaling Technology (Beverly, MA).
Statistics
Statistical significance was determined using the Student’s t-test.
Results were presented as mean±SD. A P-value of o0.05 was
considered to indicate statistical significance.
Full Materials and Methods and any associated references are
available in Supplementary Information.
CONFLICT OF INTEREST
The authors state no conflict of interest.
ACKNOWLEDGMENTS
This work was supported in part by a National Research Foundation of Korea
Grant funded by the Korean Government (KRF-2007-313-E00350) and by a
research agreement with AMOREPACIFIC Corporation.
SUPPLEMENTARY MATERIAL
Supplementary material is linked to the online version of the paper at http://
www.nature.com/jid
REFERENCES
Airola K, Fusenig NE (2001) Differential stromal regulation of MMP-1
expression in benign and malignant keratinocytes. J Invest Dermatol
116:85–92
Beavo JA, Rogers NL, Crofford OB et al. (1970) Effects of xanthine derivatives
on lipolysis and on adenosine 30,50-monophosphate phosphodiesterase
activity. Mol Pharmacol 6:597–603
Beurel E, Jope RS (2006) The paradoxical pro- and anti-apoptotic actions of
GSK3 in the intrinsic and extrinsic apoptosis signaling pathways. Prog
Neurobiol 79:173–89
Beurel E, Jope RS (2008) Differential regulation of STAT family members by
glycogen synthase kinase-3. J Biol Chem 283:21934–44
Borland G, Smith BO, Yarwood SJ (2009) EPAC proteins transduce diverse
cellular actions of cAMP. Br J Pharmacol 158:70–86
Brenneisen P, Sies H, Scharffetter-Kochanek K (2002) Ultraviolet-B irradiation
and matrix metalloproteinases: from induction via signaling to initial
events. Ann N Y Acad Sci 973:31–43
Brenneisen P, Wlaschek M, Wenk J et al. (1999) Ultraviolet-B induction of
interstitial collagenase and stromelyin-1 occurs in human dermal
fibroblasts via an autocrine interleukin-6-dependent loop. FEBS Lett
449:36–40
Chen W, Tang Q, Gonzales MS, Bowden GT (2001) Role of p38 MAP kinases
and ERK in mediating ultraviolet-B induced cyclooxygenase-2 gene
expression in human keratinocytes. Oncogene 20:3921–6
Cho S, Lee MJ, Kim MS et al. (2008) Infrared plus visible light and heat from
natural sunlight participate in the expression of MMPs and type I
procollagen as well as infiltration of inflammatory cell in human skin
in vivo. J Dermatol Sci 50:123–33
Davis RJ (2000) Signal transduction by the JNK group of MAP kinases. Cell
103:239–52
de Groot RP, Auwerx J, Bourouis M et al. (1993) Negative regulation of Jun/
AP-1: conserved function of glycogen synthase kinase 3 and the
Drosophila kinase shaggy. Oncogene 8:841–7
de Rooij J, Zwartkruis FJ, Verheijen MH et al. (1998) Epac is a Rap1 guanine-
nucleotide-exchange factor directly activated by cyclic AMP. Nature
396:474–7
Doskeland SO, Maronde E, Gjertsen BT (1993) The genetic subtypes of
cAMP-dependent protein kinase–functionally different or redundant?
Biochimica et Biophysica Acta 1178:249–58
Fang X, Yu SX, Lu Y et al. (2000) Phosphorylation and inactivation of
glycogen synthase kinase 3 by protein kinase A. Proc Natl Acad Sci USA
97:11960–5
Faour WH, He Q, Mancini A et al. (2006) Prostaglandin E2 stimulates p53
transactivational activity through specific serine 15 phosphorylation in
human synovial fibroblasts. Role in suppression of c/EBP/NF-kB-
mediated MEKK1-induced MMP-1 expression. J Biol Chem 281:
19849–60
Feliciello A, Gottesman ME, Avvedimento EV (2005) cAMP-PKA signaling
to the mitochondria: protein scaffolds, mRNA and phosphatases.
Cell Signal 17:279–87
Goode N, Hughes K, Woodgett JR et al. (1992) Differential regulation of
glycogen synthase kinase-3 b by protein kinase C isotypes. J Biol Chem
267:16878–82
Gutman A, Wasylyk B (1990) The collagenase gene promoter contains a TPA
and oncogene-responsive unit encompassing the PEA3 and AP-1 binding
sites. EMBO J 9:2241–6
Houslay MD, Adams DR (2003) PDE4 cAMP phosphodiesterases: modular
enzymes that orchestrate signalling cross-talk, desensitization and
compartmentalization. Biochem J 370:1–18
Houslay MD, Kolch W (2000) Cell-type specific integration of cross-talk
between extracellular signal-regulated kinase and cAMP signaling. Mol
Pharmacol 58:659–68
Houslay MD, Milligan G (1997) Tailoring cAMP-signalling responses through
isoform multiplicity. Trends Biochem Sci 22:217–24
Jinnin M, Ihn H, Mimura Y et al. (2005) Matrix metalloproteinase-1
up-regulation by hepatocyte growth factor in human dermal fibroblasts
via ERK signaling pathway involves Ets1 and Fli1. Nucleic Acids Res
33:3540–9
Johansson N, Ala-aho R, Uitto V et al. (2000) Expression of collagenase-3
(MMP-13) and collagenase-1 (MMP-1) by transformed keratinocytes is
www.jidonline.org 2055
C-H Park et al.
Cyclic AMP Suppresses MMP-1 Expression
dependent on the activity of p38 mitogen-activated protein kinase. J Cell
Sci 113(Part 2):227–35
Kahari VM, Saarialho-Kere U (1997) Matrix metalloproteinases in skin. Exp
Dermatol 6:199–213
Karin M (1995) The regulation of AP-1 activity by mitogen-activated protein
kinases. J Biol Chem 270:16483–6
Karin M, Hunter T (1995) Transcriptional control by protein phosphorylation:
signal transmission from the cell surface to the nucleus. Curr Biol
5:747–57
Kim HH, Shin CM, Park CH et al. (2005) Eicosapentaenoic acid inhibits UV-
induced MMP-1 expression in human dermal fibroblasts. J Lipid Res
46:1712–20
Kunisch E, Jansen A, Kojima F et al. (2009) Prostaglandin E2 differentially
modulates proinflammatory/prodestructive effects of TNF-a on synovial
fibroblasts via specific E prostanoid receptors/cAMP. J Immunol
183:1328–36
Lee YM, Kim YK, Kim KH et al. (2009) A novel role for the TRPV1 channel in
UV-induced matrix metalloproteinase (MMP)-1 expression in HaCaT
cells. J Cell Physiol 219:766–75
Li M, Wang X, Meintzer MK et al. (2000) Cyclic AMP promotes neuronal
survival by phosphorylation of glycogen synthase kinase 3b. Mol Cell
Biol 20:9356–63
Li WH, Lee YM, Kim JY et al. (2007) Transient Receptor Potential Vanilloid-1
Mediates Heat-Shock-Induced Matrix Metalloproteinase-1 Expression in
Human Epidermal Keratinocytes. J Invest Dermatol 127:2328–35
Lopez-Otin C, Palavalli LH, Samuels Y (2009) Protective roles of matrix
metalloproteinases: from mouse models to human cancer. Cell Cycle
8:3657–62
Mayr BM, Canettieri G, Montminy MR (2001) Distinct effects of cAMP and
mitogenic signals on CREB-binding protein recruitment impart specificity
to target gene activation via CREB. Proc Natl Acad Sci USA 98:10936–41
Nagase H, Visse R, Murphy G (2006) Structure and function of matrix
metalloproteinases and TIMPs. Cardiovasc Res 69:562–73
Nagase H, Woessner JF Jr (1999) Matrix metalloproteinases. J Biol Chem
274:21491–4
Park CH, Lee MJ, Ahn J et al. (2004) Heat shock-induced matrix
metalloproteinase (MMP)-1 and MMP-3 are mediated through ERK and
JNK activation and via an autocrine interleukin-6 loop. J Invest Dermatol
123:1012–9
Peters-Golden M (2009) Putting on the brakes: cyclic AMP as a multipronged
controller of macrophage function. Sci Signal 2:pe37
Reunanen N, Li SP, Ahonen M et al. (2002) Activation of p38 a CPK enhances
collagenase-1 (matrix metalloproteinase (MMP)-1) and stromelysin-1
(MMP-3) expression by mRNA stabilization. J Biol Chem 277:32360–8
Reunanen N, Westermarck J, Hakkinen L et al. (1998) Enhancement of
fibroblast collagenase (matrix metalloproteinase-1) gene expression by
ceramide is mediated by extracellular signal-regulated and stress-
activated protein kinase pathways. J Biol Chem 273:5137–45
Rittie L, Fisher GJ (2002) UV-light-induced signal cascades and skin aging.
Ageing Res Rev 1:705–20
Rocques N, Abou Zeid N, Sii-Felice K et al. (2007) GSK-3-mediated phos-
phorylation enhances Maf-transforming activity. Mol Cell 28:584–97
Rosenberg D, Groussin L, Jullian E et al. (2002) Role of the PKA-regulated
transcription factor CREB in development and tumorigenesis of
endocrine tissues. Ann N Y Acad Sci 968:65–74
Salvatori R, Guidon PT Jr, Rapuano BE et al. (1992) Prostaglandin E1 inhibits
collagenase gene expression in rabbit synoviocytes and human
fibroblasts. Endocrinology 131:21–8
Schmidt-Ott KM, Xu AD, Tuschick S et al. (2001) Hypoxia reverses dibutyryl-
cAMP-induced stellation of cultured astrocytes via activation of the
endothelin system. FASEB J 15:1227–9
Schmitt JM, Stork PJ (2002) PKA phosphorylation of Src mediates cAMP’s
inhibition of cell growth via Rap1. Mol Cell 9:85–94
Schroeder P, Lademann J, Darvin ME et al. (2008) Infrared radiation-induced
matrix metalloproteinase in human skin: implications for protection.
J Invest Dermatol 128:2491–7
Seamon KB, Padgett W, Daly JW (1981) Forskolin: unique diterpene activator
of adenylate cyclase in membranes and in intact cells. Proc Natl Acad
Sci USA 78:3363–7
Smith WL, Langenbach R (2001) Why there are two cyclooxygenase
isozymes. J Clin Invest 107:1491–5
Steinbrecher KA, Wilson W III, Cogswell PC et al. (2005) Glycogen synthase
kinase 3b functions to specify gene-specific, NF-kB-dependent transcrip-
tion. Mol Cell Biol 25:8444–55
Sternlicht MD, Werb Z (2001) How matrix metalloproteinases regulate cell
behavior. Annu Rev Cell Dev Biol 17:463–516
Stork PJ, Schmitt JM (2002) Crosstalk between cAMP and MAP kinase
signaling in the regulation of cell proliferation. Trends Cell Biol 12:
258–66
Sugimoto Y, Narumiya S (2007) Prostaglandin E receptors. J Biol Chem 282:
11613–7
Sunahara RK, Taussig R (2002) Isoforms of mammalian adenylyl cyclase:
multiplicities of signaling. Mol Interventions 2:168–84
Torii K, Nishizawa K, Kawasaki A et al. (2008) Anti-apoptotic action of Wnt5a
in dermal fibroblasts is mediated by the PKA signaling pathways.
Cell Signal 20:1256–66
Westermarck J, Holmstrom T, Ahonen M et al. (1998) Enhancement of
fibroblast collagenase-1 (MMP-1) gene expression by tumor promoter
okadaic acid is mediated by stress-activated protein kinases Jun
N-terminal kinase and p38. Matrix Biol 17:547–57
Woessner JF Jr (1998) Role of matrix proteases in processing enamel proteins.
Connect Tissue Res 39:69–73
Woolson HD, Thomson VS, Rutherford C et al. (2009) Selective inhibition of
cytokine-activated extracellular signal-regulated kinase by cyclic AMP
via Epac1-dependent induction of suppressor of cytokine signalling-3.
Cell Signal 21:1706–15
Zhang J, Wang Q, Zhu N et al. (2008) Cyclic AMP inhibits JNK
activation by CREB-mediated induction of c-FLIP(L) and MKP-1,
thereby antagonizing UV-induced apoptosis. Cell Death Differ 15:
1654–62
Zhang X, Odom DT, Koo SH et al. (2005) Genome-wide analysis of cAMP-
response element binding protein occupancy, phosphorylation, and
target gene activation in human tissues. Proc Natl Acad Sci USA
102:4459–64
2056 Journal of Investigative Dermatology (2010), Volume 130
C-H Park et al.
Cyclic AMP Suppresses MMP-1 Expression
